Stocks and Investing Stocks and Investing
Tue, November 6, 2018
Mon, November 5, 2018

David Risinger Upgraded (BHC) to Buy on, Nov 5th, 2018


Published on 2024-10-26 10:26:04 - WOPRAI, David Risinger
  Print publication without navigation


David Risinger of Morgan Stanley, Upgraded "Bausch Health Companies Inc." (BHC) to Buy on, Nov 5th, 2018.

David has made no other calls on BHC in the last 4 months.



There are 3 other peers that have a rating on BHC. Out of the 3 peers that are also analyzing BHC, all agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Douglas Miehm of "RBC Capital" Maintained at Hold with Increased Target to $30 on, Monday, October 8th, 2018
  • David Amsellem of "Piper Sandler" Upgraded from Sell to Hold and Increased Target to $19 on, Thursday, September 13th, 2018
  • Gary Nachman of "BMO Capital" Maintained at Hold with Increased Target to $22 on, Monday, August 13th, 2018
Contributing Sources